Clostridium difficile infection in Europe: a hospital-based survey (Q58007978)

5

object named as

Mark H Wilcox

0 references

Maja Rupnik

6

object named as

Maja Rupnik

0 references

Hanna Pituch

1 reference

ORCID Public Data File 2021

Fidelma Fitzpatrick

1 reference

ORCID Public Data File 2021

author name string

Martijn P Bauer

1

0 references

Daan W Notermans

2

0 references

Birgit HB van Benthem

3

0 references

Jon S Brazier

4

0 references

Dominique L Monnet

7

0 references

Jaap T van Dissel

8

0 references

Birgit H B van Benthem

3

0 references

Mark H Wilcox

Emergence of Clostridium difficile-associated disease in North America and Europe.

5

0 references

language of work or name

English

0 references

publication date

January 2011

0 references

1 January 2011

0 references

published in

The Lancet

0 references

volume

377

0 references

issue

9759

0 references

page(s)

63-73

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Clostridium difficile--more difficult than ever

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

An epidemic, toxin gene-variant strain of Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Clostridium difficile infection: new developments in epidemiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Clostridium difficile ribotype 027, toxinotype III, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

A European survey of diagnostic methods and testing protocols for Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Recommendations for surveillance of Clostridium difficile-associated disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Simulation study of confounder-selection strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Rates of Clostridium difficile infection in patients discharged from Spanish hospitals, 1997-2005.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Clostridium difficile in discharged inpatients, Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Prevalence of Clostridium difficile in diarrhoeic and non-diarrhoeic piglets.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Clostridium difficile in retail meat products, USA, 2007

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Toxinotype V Clostridium difficile in humans and food animals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Clinical risk factors for severe Clostridium difficile-associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Spread and Epidemiology of Clostridium difficile Polymerase Chain Reaction Ribotype 027/Toxinotype III in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021

Risk factors for severity and relapse of pseudomembranous colitis in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961266-4

7 January 2021